EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Antenatal Intravenous Iron Therapy in Anemic Pregnancies: Associations with Obstetric Patient Blood Management and Neonatal Outcomes

Eleonora Romani iD, Francesca Parisi, Sara Zullino, Chiara Lubrano iD, Silvia Balestri, Clara Massari, Salvatore Barresi, Massimo Micaglio iD, Felice Petraglia, Irene Cetin iD, Federico Mecacci

Nutrients · 2026

DOI: 10.3390/nu18193169 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Nutrients, 2026. Verfasst von Eleonora Romani und 10 weiteren Autor:innen. Beteiligte Einrichtung: Obstetrics and Gynaecology Unit, Department of Experimental and Clinical Biomedical Sciences, University of Florence, 50134 Florence, Italy. Hauptthemen laut MEDLINE: Anemia, Iron-Deficiency, Iron, Pregnancy Complications, Hematologic, Prenatal Care. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Milan, University of Florence, Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Anemia in pregnancy is associated with increased maternal and neonatal morbidity, most commonly due to iron deficiency. The effect of antenatal IV iron therapy on obstetric patient blood management (PBM) and neonatal outcomes remains uncertain.

Objective

To evaluate whether antenatal IV iron therapy in pregnancy is associated with improved obstetric PBM, specifically reduced RBC transfusion and postpartum IV iron use, and improved neonatal outcomes.

Methods

In this multicenter retrospective study, 851 pregnant women with IDA were included (490 received antenatal IV iron; 361 controls). Multivariable logistic regression adjusted for clinically relevant confounders assessed maternal and neonatal outcomes. A propensity score-adjusted sensitivity analysis addressed baseline differences.

Results

The median gestational age at infusion was 35 weeks (range 30–37). The treated group had a higher obstetric risk profile, lower baseline hemoglobin at 9.2 (range 5.5–12.7) vs. 9.8 (range 7.9–12) g/dL, and more frequent oral iron use (30–100 mg/day; 66.1% vs. 53.7%; p < 0.001). Gestational age at delivery, estimated blood loss, and postpartum hemorrhage were similar between groups. After adjustment, antenatal IV iron therapy was associated with 56% and 72% lower odds of RBC transfusion and postpartum IV iron use, respectively; the reduced odds of blood transfusion remained significant after propensity score adjustment (aOR 0.42, 95%CI 0.16–0.99). A significant interaction with baseline hemoglobin was observed, with benefit mainly in women with a lower baseline. Neonatal outcomes were similar between groups, although NICU/high-dependency admission and phototherapy for jaundice were less frequent among neonates of treated women.

Conclusions

Antenatal IV iron therapy was associated with reduced transfusion exposure and lower postpartum IV iron requirements, despite lower baseline Hb values. These findings support antenatal hematologic optimization in obstetric PBM and highlight the need for further studies to clarify potential neonatal benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Iron-DeficiencyIronPregnancy Complications, HematologicPrenatal CareAdultFemaleHumansInfant, NewbornPregnancyAdministration, IntravenousBlood TransfusionErythrocyte TransfusionGestational AgeHemoglobinsPregnancy OutcomePropensity ScoreRetrospective Studies

Stichwörter der Autor:innen

anemiablood transfusioninfantiron deficiencypregnancy

Substanzen

HemoglobinsIron

Autor:innen und Institutionen

  • Obstetrics and Gynaecology Unit, Department of Experimental and Clinical Biomedical Sciences, University of Florence, 50134 Florence, Italy.
  • Complex Obstetrics Unit, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Department of Biomedical and Clinical Sciences, University of Milan, 20157 Milan, Italy.
  • High Risk Pregnancy Unit, Department for Women and Health, Careggi University Hospital, 50134 Florence, Italy.
  • Nutritional Sciences-Doctoral Programme, Department of Veterinary Medicine and Animal Sciences (DIVAS), University of Milan, 26900 Lodi, Italy.
  • Department of Anesthesia and Intensive Care, Careggi University Hospital, 50134 Florence, Italy.

ORCID-Profile: Eleonora Romani, Chiara Lubrano, Massimo Micaglio, Irene Cetin

Förderung

  • University of Milan
  • University of Florence
  • Italian Ministry of Health

Zitieren

APA

Romani, E., Parisi, F., Zullino, S., Lubrano, C., Balestri, S., Massari, C., Barresi, S., Micaglio, M., Petraglia, F., Cetin, I., & Mecacci, F. (2026). Antenatal Intravenous Iron Therapy in Anemic Pregnancies: Associations with Obstetric Patient Blood Management and Neonatal Outcomes. Nutrients. https://doi.org/10.3390/nu18193169

Vancouver

Romani E, Parisi F, Zullino S, Lubrano C, Balestri S, Massari C, et al. Antenatal Intravenous Iron Therapy in Anemic Pregnancies: Associations with Obstetric Patient Blood Management and Neonatal Outcomes. Nutrients. 2026. doi:10.3390/nu18193169

BibTeX
@article{Romani2026,
  author = {Romani, Eleonora and Parisi, Francesca and Zullino, Sara and Lubrano, Chiara and Balestri, Silvia and Massari, Clara and Barresi, Salvatore and Micaglio, Massimo and Petraglia, Felice and Cetin, Irene and Mecacci, Federico},
  title = {Antenatal Intravenous Iron Therapy in Anemic Pregnancies: Associations with Obstetric Patient Blood Management and Neonatal Outcomes},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18193169}
}
Kostenlos starten →